Publications

Research Support, Non-U.S. Gov't
News
Ppublish 2 citations
Electronic publication date
April 25, 2024

View on Pubmed.gov 38325356 | View on doi.org 10.1159/0005356...

Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells.

Search for publications in this journal J Innate Immun - 16(1):133-142

Abstract

INTRODUCTION

Coronavirus disease 2019 caused by coronavirus-2 (SARS-CoV-2) has emerged as an aggressive viral pandemic. Health care providers confront a challenging task for rapid development of effective strategies to combat this and its long-term after effects. Virus entry into host cells involves interaction between receptor-binding domain (RBD) of spike (S) protein S1 subunit with angiotensin converting enzyme present on host cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a moonlighting enzyme involved in cellular glycolytic energy metabolism and micronutrient homeostasis. It is deployed in various cellular compartments and the extra cellular milieu. Though it is known to moonlight as a component of mammalian innate immune defense machinery, till date its role in viral restriction remains unknown.

METHOD

Recombinant S protein, the RBD, and human GAPDH protein were used for solid phase binding assays and biolayer interferometry. Pseudovirus particles expressing four different strain variants of S protein all harboring ZsGreen gene as marker of infection were used for flow cytometry-based infectivity assays.

RESULTS

Pseudovirus entry into target cells in culture was significantly inhibited by addition of human GAPDH into the extracellular medium. Binding assays demonstrated that human GAPDH binds to S protein and RBD of SARS-CoV-2 with nanomolar affinity.

CONCLUSIONS

Our investigations suggest that this interaction of GAPDH interferes in the viral docking with hACE2 receptors, thereby affecting viral ingress into mammalian cells.

References

Proteins. 2017 Mar;85(3):435-444

Biochem Biophys Res Commun. 1987 Feb 27;143(1):403-9

FASEB J. 2017 Jun;31(6):2638-2648

Free Radic Biol Med. 2023 Nov 1;208:186-193

Cited by 2 citations (total)

Journal Article

Analysis of Multi-Target Synergistic Mechanism of Coix Seed Therapy for Herpes Zoster Based on Machine Learning and Network Pharmacology.

Electronic publication date May 28, 2025

Search for publications in this journal Genes (Basel)

Zhiqin Song [...] Mingkai Wu et al.

OBJECTIVE

To explore the efficacy and mechanism of Coix seeds in treating herpes zoster (HZ) using an integrated computational approach.

METHODS

Network pharmacology,...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances

Copyright

© 2024 The Author(s). Published by S. Karger AG, Basel.